V Raymond

4-demethoxydaunorubicin (idarubicin) in combination with 1-beta-D-arabinofuranosylcytosine in the treatment of relapsed or refractory acute leukemia.

Ellin Berman, V Raymond, Aiman N. Daghestani et al. · PubMed · 1989 · 24 citations

Mixed-phenotype Acute Leukemia, Refractory Leukemia, Pharmacotherapy +17

Phase II evaluation of orally administered idarubicin in patients with advanced breast cancer.

E. S. Casper, V Raymond, Thomas B. Hakes et al. · PubMed · 1987 · 12 citations

Advanced Breast Cancer, Phase Ii Evaluation, Oncology +6

Phase II trial of 4'-deoxydoxorubicin in patients with advanced breast cancer.

S P Leitner, E. S. Casper, Thomas B. Hakes et al. · PubMed · 1985 · 11 citations

Advanced Breast Cancer, Breast Oncology, Phase Ii Trial +11

Phase II study of 4-demethoxydaunorubicin in advanced ovarian carcinoma.

T. Hakes, Aiman N. Daghestani, James Dougherty et al. · PubMed · 1985 · 11 citations

Advanced Ovarian Carcinoma, Cancer Treatment, Oncology +2

Phase II Study of Idarubicin in Advanced Cervical Carcinoma

Thomas B. Hakes, James Dougherty, V Raymond · American Journal of Clinical Oncology · 1986 · 10 citations

Cervical Cancer, Phase Ii Trial, Health Sciences +12